The following sections dissect the molecular interplay between TMAO, PERK, NF-κB, and NLRP3, providing a roadmap to understand how microbial metabolites shape immune outcomes in IBD (Figure 2). This evidence concerns the gene NFKB1 and inflammatory bowel disease.